Part, Chapter, Paragraph
1 II, 5. 1. 1| susceptible individuals.~ ~· Parkinson’s Disease~The cause of the
2 II, 5. 1. 1| neurodegenerative process of Parkinson’s Diseases is still unknown.~ ~·
3 II, 5. 5. 3| Multiple System Atrophy~PD~Parkinson’s disease~PSP~Progressive
4 II, 5. 5. 3| 5.5.3.6. Parkinson’s disease~ ~ ~
5 II, 5. 5. 3| 5.3.6.1. Introduction~ ~Parkinson’s disease (PD) is one of
6 II, 5. 5. 3| contributing to its burden (Global Parkinson’s Disease Survey Steering
7 II, 5. 5. 3| total number of cases of Parkinson’s disease in Europe~ ~Figure
8 II, 5. 5. 3| total number of cases of Parkinson’s disease in selected EUGLOREH
9 II, 5. 5. 3| 1. Incidence studies of Parkinson’s disease in Europe.~ ~Crude
10 II, 5. 5. 3| 2. Prevalence studies of Parkinson’s disease in Europe.~ ~Estimates
11 II, 5. 5. 3| 5.3.6.3. Distribution of Parkinson’s disease cases according
12 II, 5. 5. 3| 5.3.6.3. Distribution of Parkinson’s disease cases according
13 II, 5. 5. 3| in those patients (Global Parkinson’s Disease Survey Steering
14 II, 5. 5. 3| Figure 5.5.3.6.3. Cost of Parkinson’s disease stratified by
15 II, 5. 5. 3| neurodegenerative process in Parkinson’s disease is still unknown.
16 II, 5. 5. 3| Purely genetic forms of Parkinson’s disease have been identified,
17 II, 5. 5. 3| with a decreased risk for Parkinson’s disease (Elbaz and Tranchant,
18 II, 5. 5. 3| with increased or decreased Parkinson’s disease risk, but the
19 II, 5. 5. 3| Commission for people with Parkinson’s disease. Most plans and
20 II, 5. 5. 3| Diagnosis and Therapy of Parkinson’s Disease - was a multinational
21 II, 5. 5. 3| clinically well defined Parkinson’s disease out-patients,
22 II, 5. 5. 3| and patient utilities of Parkinson’s disease. (EuroPa Consortium,
23 II, 5. 5. 3| Andlin-Sobocki et al, 2005). Parkinson’s disease has been selected
24 II, 5. 5. 3| nursing home placement in Parkinson’s disease: a population-based,
25 II, 5. 5. 3| in prevalence surveys of Parkinson’s disease. Mov Disord 13(
26 II, 5. 5. 3| 1999): Dietary factors in Parkinson’s disease: the role of food
27 II, 5. 5. 3| Amaducci L, Inzitari D (2000): Parkinson’s disease and parkinsonism
28 II, 5. 5. 3| JF (2004): Prevalence of Parkinson’s disease and other types
29 II, 5. 5. 3| 2006): Nongenetic causes of Parkinson’s disease. Journal of neural
30 II, 5. 5. 3| D (1998): Prevalence of Parkinson’s disease in Northwestern
31 II, 5. 5. 3| The health burdens of Parkinson’s disease. Mov Disord 13(
32 II, 5. 5. 3| Quality of life and care in Parkinson’s disease. Br J Clin Pract
33 II, 5. 5. 3| J (2002): Prevalence of Parkinson’s disease in Cantalejo,
34 II, 5. 5. 3| D (1987): Prevalence of Parkinson’s disease in the Republic
35 II, 5. 5. 3| A (1995): Prevalence of Parkinson’s disease in the elderly:
36 II, 5. 5. 3| Prevalence of parkinsonism and Parkinson’s disease in Europe: the
37 II, 5. 5. 3| Action on the Epidemiology of Parkinson’s disease. Journal of neurology,
38 II, 5. 5. 3| The economic impact of Parkinson’s disease. An estimation
39 II, 5. 5. 3| Projected number of people with Parkinson disease in the most populous
40 II, 5. 5. 3| life and economic impact of Parkinson’s disease. Drugs Aging 23(
41 II, 5. 5. 3| mortality and cause of death in Parkinson disease. Versicherungsmedizin /
42 II, 5. 5. 3| environmental exposures in Parkinson's disease. J Neurol Sci.
43 II, 5. 5. 3| J (1999): Prevalence of Parkinson’s disease in lower Aragon,
44 II, 5. 5. 3| for Clinical Research of Parkinson’s Disease. Moving Along
45 II, 5. 5. 3| Epidemiology and therapy of Parkinson disease in inpatient nursing
46 II, 5. 5. 3| influencing the risk of Parkinson's disease: a case-control
47 II, 5. 5. 3| Direct economic impact of Parkinson’s disease: a research survey
48 II, 5. 5. 3| Update on the genetics of Parkinson’s disease. Mov Disord 22
49 II, 5. 5. 3| Suppl 17:S343-350.~Global Parkinson’s Disease Survey Steering
50 II, 5. 5. 3| impacting on quality of life in Parkinson’s disease: results from
51 II, 5. 5. 3| home placement in advanced Parkinson’s disease. Neurology 43(
52 II, 5. 5. 3| Peterson EL (1999): Smoking and Parkinson’s disease: a dose-response
53 II, 5. 5. 3| Multiple risk factors for Parkinson’s disease. J Neurol Sci
54 II, 5. 5. 3| VC, De Bastiani P (1991): Parkinson’s disease in Ferrara, Italy,
55 II, 5. 5. 3| sydney multicentre study of Parkinson’s disease: progression and
56 II, 5. 5. 3| Sydney Multicenter Study of Parkinson’s disease: non-L-dopa-responsive
57 II, 5. 5. 3| The natural history of Parkinson’s disease in the pre-levodopa
58 II, 5. 5. 3| therapeutic management of Parkinson’s disease. Report of a joint
59 II, 5. 5. 3| I: early (uncomplicated) Parkinson’s disease. Eur J Neurol
60 II, 5. 5. 3| diagnosis of idiopathic Parkinson’s disease: a clinico-pathological
61 II, 5. 5. 3| environmental risk factors for Parkinson’s disease. Parkinsonism
62 II, 5. 5. 3| of French patients with Parkinson’s disease. Pharmacoeconomics
63 II, 5. 5. 3| Dodel R (2005): Cost of Parkinson’s disease in Europe. Eur
64 II, 5. 5. 3| environmental risk factors in Parkinson disease: what is the evidence?
65 II, 5. 5. 3| Predicting the cost of Parkinson’s disease. Mov Disord 22(
66 II, 5. 5. 3| Paterson JG, Roy SK (1986): Parkinson’s disease in a Scottish
67 II, 5. 5. 3| A (2003): Prevalence of Parkinson’s disease: a door-to-door
68 II, 5. 5. 3| Smoking, nicotine and Parkinson’s disease. Trends Neurosci
69 II, 5. 5. 3| patients with idiopathic Parkinson’s disease : Results from
70 II, 5. 5. 3| Study on Epidemiology of Parkinson’s Disease with Dementia (
71 II, 5. 5. 3| 1979): The frequency of Parkinson’s disease in the Province
72 II, 5. 5. 3| Devoto MC (1980): The risk of Parkinson disease in Mediterranean
73 II, 5. 5. 3| and motor fluctuations in Parkinson’s disease. A community-based
74 II, 5. 5. 3| 1973): Social costs of Parkinson’s disease. J Chronic Dis
75 II, 5. 5. 3| illness and its predictors for Parkinson’s disease in Germany. Pharmacoeconomics
76 II, 5. 5. 3| B, McQuillan WJ (1985): Parkinson’s disease in the district
77 II, 5. 5. 3| 2000): Epidemiology of Parkinson’s disease and akinetic syndromes.
78 II, 5. 5. 3| 2003): Is the cause of Parkinson’s disease environmental
79 II, 5. 5. 3| of incidence studies of Parkinson’s disease. Mov Disord 18(
80 II, 5. 5. 3| and survival in idiopathic Parkinson’s disease: Olmsted County
81 II, 5. 5. 3| incidence and prevalence of Parkinson’s disease in the elderly
82 II, 5. 5. 3| Prevalence and incidence of Parkinson’s disease in Europe. Eur
83 II, 5. 5. 3| M (1997): The burden of Parkinson’s disease on society, family,
84 II, 5. 5. 3| HY~Hoehn & Yahr scale~PD~Parkinson’s disease~SMR~Standardized
85 Key, Ap5. 0. 0| paratyphi~paratyphoid~parental~parkinson~particles~particulate~pathogens~
